IPA
Price
$0.67
Change
-$0.03 (-4.29%)
Updated
Jun 6 closing price
Capitalization
30.77M
TPST
Price
$8.25
Change
+$0.31 (+3.90%)
Updated
Jun 6 closing price
Capitalization
30.36M
61 days until earnings call
Interact to see
Advertisement

IPA vs TPST

Header iconIPA vs TPST Comparison
Open Charts IPA vs TPSTBanner chart's image
ImmunoPrecise Antibodies
Price$0.67
Change-$0.03 (-4.29%)
Volume$630.98K
Capitalization30.77M
Tempest Therapeutics
Price$8.25
Change+$0.31 (+3.90%)
Volume$224.12K
Capitalization30.36M
IPA vs TPST Comparison Chart
Loading...
IPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPA vs. TPST commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPA is a Hold and TPST is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (IPA: $0.67 vs. TPST: $8.25)
Brand notoriety: IPA and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPA: 131% vs. TPST: 151%
Market capitalization -- IPA: $30.77M vs. TPST: $30.36M
IPA [@Biotechnology] is valued at $30.77M. TPST’s [@Biotechnology] market capitalization is $30.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPA’s FA Score shows that 1 FA rating(s) are green whileTPST’s FA Score has 0 green FA rating(s).

  • IPA’s FA Score: 1 green, 4 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, IPA is a better buy in the long-term than TPST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPA’s TA Score shows that 4 TA indicator(s) are bullish while TPST’s TA Score has 3 bullish TA indicator(s).

  • IPA’s TA Score: 4 bullish, 4 bearish.
  • TPST’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IPA is a better buy in the short-term than TPST.

Price Growth

IPA (@Biotechnology) experienced а +17.96% price change this week, while TPST (@Biotechnology) price change was +38.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

IPA is expected to report earnings on Mar 28, 2025.

TPST is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPA($30.8M) and TPST($30.4M) have the same market capitalization . IPA YTD gains are higher at: 63.323 vs. TPST (-23.992). TPST has higher annual earnings (EBITDA): -40.14M vs. IPA (-45.11M). IPA has less debt than TPST: IPA (12.9M) vs TPST (15.4M). IPA has higher revenues than TPST: IPA (24M) vs TPST (0).
IPATPSTIPA / TPST
Capitalization30.8M30.4M101%
EBITDA-45.11M-40.14M112%
Gain YTD63.323-23.992-264%
P/E RatioN/AN/A-
Revenue24M0-
Total Cash12.9MN/A-
Total Debt12.9M15.4M84%
FUNDAMENTALS RATINGS
IPA vs TPST: Fundamental Ratings
IPA
TPST
OUTLOOK RATING
1..100
2822
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9697
PRICE GROWTH RATING
1..100
3664
P/E GROWTH RATING
1..100
10089
SEASONALITY SCORE
1..100
n/a65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IPA's Valuation (26) in the null industry is in the same range as TPST (50) in the Pharmaceuticals Major industry. This means that IPA’s stock grew similarly to TPST’s over the last 12 months.

IPA's Profit vs Risk Rating (100) in the null industry is in the same range as TPST (100) in the Pharmaceuticals Major industry. This means that IPA’s stock grew similarly to TPST’s over the last 12 months.

IPA's SMR Rating (96) in the null industry is in the same range as TPST (97) in the Pharmaceuticals Major industry. This means that IPA’s stock grew similarly to TPST’s over the last 12 months.

IPA's Price Growth Rating (36) in the null industry is in the same range as TPST (64) in the Pharmaceuticals Major industry. This means that IPA’s stock grew similarly to TPST’s over the last 12 months.

TPST's P/E Growth Rating (89) in the Pharmaceuticals Major industry is in the same range as IPA (100) in the null industry. This means that TPST’s stock grew similarly to IPA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IPATPST
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 30 days ago
90%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRDN14.680.44
+3.09%
Viridian Therapeutics
IR83.121.25
+1.53%
Ingersoll Rand
SANM87.161.13
+1.31%
Sanmina Corp
REFI14.360.07
+0.49%
Chicago Atlantic Real Estate Finance
CASI1.86-0.01
-0.44%
CASI Pharmaceuticals